To be Canadian is to be the best version of ourselves, for each other and for others. Foundational to this vision is the ability to enjoy good health and wellbeing. This is the purpose that makes us who we are – a fast growing Canadian cannabis company that provides innovative, superior, cost-effective cannabis solutions.
TerrAscend is a Canadian owned, operated, and publicly traded cannabis company.
We are based in Mississauga – a great city that is leading today for tomorrow. We are strategically located in the city’s Life Sciences hub, a vertically integrated Cannabis company with quality products and services that meet the evolving needs of our clients.
Terra: Earth, land
Ascend: to climb, to rise to a higher point, rank
Our Aboriginal communities believe the hummingbird teaches us to appreciate and love the miracle of being alive. It is often portrayed as a healer or spirit being that helps people in need. It is said that if a hummingbird appears during a time of great sorrow and pain, it means healing is sure to follow.
Even as we ascend new heights to heal, we stay grounded in our core values of innovation and quality.
We are committed to providing the best cannabis in Canada and around the world.
To be the best, we hired the best.
Basem Hanna is the President and Chief Executive Officer of TerrAscend.
Basem has deep expertise in finance, real estate and corporate operations and founded the real estate fund Almega Capital Limited Partnership in 2011. Almega currently has a assets valued at over $30 million across Ontario.
Basem has a B.A. (Hons.) in Business Administration from the Richard Ivey School of Business at Western University.
Michael Nashat is the Chief Operating Officer of TerrAscend.
Michael is the former Executive Director of the OnPharm Independent Pharmacy Group, which represents the commercial interests of over 340 pharmacies with annual sales of over $300 million.
Michael is a former board member with the Ontario College of Pharmacists, Canadian Foundation for Pharmacy, and the Canadian Association of Chain Drug Stores. He is also a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council, and currently serves as the Co-chair of the Ontario Pharmacists Association’s Owners Advisory Council.
Michael has a Pharm.D. from the Albany College of Pharmacy and Health Science, and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Bristol Myers Squibb/Rutgers University in New Jersey, U.S.
Vijay Sappani is the Chief Strategy Officer of TerrAscend.
Vijay held senior positions with Natco Pharma (Canada) Inc. and Biovail. He also served as Senior Special Assistant to the Ontario Minister of Health and Long Term Care and was a member of the board for the ministry’s Pharmacy Council as well as the Katz Group’s advisory council for self-distribution. Additionally, Vijay has served on the boards of several organizations and is an active community volunteer.
Vijay has a B. Pharm. from the Tamil Nadu Dr. MGR Medical University in Chennai, India and a post-graduate diploma in Marketing Management from the Business School at Humber College.
Mike Dai is the Chief Financial Officer of TerrAscend.
Mike has extensive experience working in a variety of audit, advisory, M&A and valuation engagements. He has been involved in a number of public and private market transactions, including business acquisitions and reverse takeovers, both domestically and internationally.
Mike is an alumunus of Grant Thornton LLP and obtained his Master of Accounting from the University of Waterloo.
Dr. Gopal Bhatnagar is a Director of TerrAscend.
Gopal is the Head of the Cardiovascular Surgery Unit at the Trillium Health Centre and was the former Chief of Staff at the Centre. He is also an Assistant Professor of Surgery at the University of Toronto.
Gopal is the co-founder of one of the largest e-cigarette suppliers and retailers in Canada. He also previously served on the Canadian Forces as part of the medical corps and on the Canadian Armed Reserve Forces.
Gopal received his M.D. from the University of Western Ontario.
Richard Mavrinac is a Director of TerrAscend.
Richard has served as the Chief Financial Officer of George Weston Limited and Executive Vice President of Loblaw Companies Limited.
Richard began his career with Loblaw Companies Limited holding a variety of senior financial positions including Senior Vice President, Finance for George Weston Limited and Loblaw Companies Limited.
Richard has a B.Com. from the University of Toronto and is a Chartered Professional Accountant.
Dr. Jamie Newman is the Chief Medical Officer of Terra Health Network.
Jamie is a practising Gastroenterologist and Internal Medicine physician.
Jamie has been working for over 19 years and is a full time staff member at Trillium Health Partners, the largest hospital organization in Ontario. He is the Head of Gastroenterology and Endoscopy at the Mississauga Site. He is also the CEO of Vector Health Clinics that currently has nine locations across Ontario, and was a former Medical Advisor to the Teal Group of Companies that focuses on educating and linking together patients, health care providers, and licensed cannabis producers.
Jamie received his M.D. from the University of Toronto, and has a B.A. (Hons.) in Economics from Western University.
André Albinati is a Principal Partner at the Earnscliffe Strategy Group, and the public affairs Advisor to TerrAscend.
Prior to joining Earnscliffe, André served as Senior Policy Advisor to a number of Federal cabinet ministers responsible for International Cooperation, Human Resources Development Canada, and International Trade. He also served on the transition team for an incoming Prime Minister. André has spent a decade advising patient groups and research based organizations, as well as biotechnology and innovative pharmaceutical industry associations and companies.
André is currently a board member at the Canadian Science Policy Centre and also sits as President of the Government Relation Institute of Canada. He has a B.A. (Hons.) in Political Science from University of Alberta.
We have five emerging ventures that embody our values of innovation and superior quality.
Solace Health is a research and development medical cannabis company that has a pending application to become a licensed producer and distributor of medical cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Solace Heath’s 67,000 square foot production facility encompasses the highest level of security and adheres to strict environmental and research practices.
Solace Health’s industry-leading healthcare professionals and expert production staff collaborate with key stakeholders, healthcare professionals, and patients to develop superior medical marijuana that is safe, efficacious and exceeds the highest regulatory standards to improve patient quality of life.
Terra Health Network is a research based Cannabinoid medical clinic group that is at the cross roads of Cannabinoid education and patient care. Terra Health Network strives to empower patients to achieve optimal well-being, living happier and healthier lives.
Terra Health Network is committed to providing state of the art prescription cannabinoids and innovative medical cannabis solutions for Canadians suffering from chronic pain and debilitating illnesses.
We are also working on:
Earnscliffe is Canada’s most experienced public affairs firm, and a recognized leader in government relations, strategic communications, public policy analysis and opinion and market research.It operates from offices in Ottawa, Ontario, Quebec, Alberta, Saskatchewan and British Columbia, as well as rep offices in Beijing and Brussels through our partnership with Fipra, an international network of independent firms.
Earnscliffe leadership team includes former government policymakers, business leaders, academics, award-winning journalists and public opinion analysts who support TerrAscend with a unique understanding of the country and where it intersects with the world.
TerrAscend trades under the ticker symbol TER on the Canadian Securities Exchange.
To learn more about investing in TerrAscend:
Subscribe to our investor news and updates